GMED
Globus Medical
74.50$
+0.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 35.8% | 37.7% | 37.0% | 38.5% | 40.4% | 41.5% | 36.3% | 34.9% | 37.8% | 40.1% | 40.4% | 40.4% | |
| 5.2% | 9.2% | 7.2% | 8.2% | 12.2% | 14.9% | 9.8% | 4.6% | 7.3% | 9.9% | 10.3% | 9.3% | |
| 8.8% | 10.2% | 8.8% | 9.9% | 13.7% | 16.9% | 9.8% | 4.6% | 7.7% | 10.5% | 11.6% | 10.8% | |
| 9.3% | 9.9% | 10.8% | 12.3% | 11.7% | 11.0% | 11.4% | 13.3% | 13.5% | 14.0% | 13.5% | 13.5% | |
| 16.9% | 16.7% | 16.5% | 15.4% | 14.1% | 12.6% | 14.1% | 15.6% | 15.1% | 14.3% | 14.2% | 14.8% | |
| 13.1% | – | – | – | – | – | – | – | – | – | – | – | |
| 21.0% | 28.2% | 29.4% | 29.1% | 28.1% | 27.3% | 30.4% | 28.9% | 28.1% | 27.1% | 26.4% | 26.2% | |
| 23.6% | 18.2% | 18.0% | 17.4% | 16.6% | 15.1% | 16.4% | 16.1% | 15.2% | 14.1% | 13.3% | 12.6% | |
| 21.8% | 21.4% | 20.7% | 20.4% | 20.0% | 20.5% | 13.2% | 13.4% | 13.7% | 13.8% | 13.0% | 13.1% | |
| 8.0% | 7.7% | 15.9% | 15.9% | 16.1% | 16.3% | 8.2% | 8.6% | 9.1% | 9.4% | 8.9% | 8.7% | |
| 0.2% | 0.2% | 8.8% | 8.8% | 8.8% | 8.6% | 0.2% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | |
| 1.6% | 1.1% | 1.0% | 1.3% | 1.1% | 1.4% | 1.6% | 1.8% | 1.7% | 1.9% | 1.9% | 1.9% | |
| 7.6% | 8.2% | – | – | – | – | – | – | – | – | – | – | |
| 78.2% | 78.6% | 79.3% | 79.6% | 80.0% | 79.5% | 86.8% | 86.6% | 86.3% | 86.2% | 87.0% | 86.9% | |
| 25.2% | 22.4% | 21.2% | 21.5% | 22.1% | 22.0% | 22.0% | 24.5% | 25.4% | 26.2% | 27.8% | 27.8% | |
| 2.2% | 2.7% | 2.7% | 2.7% | 2.7% | 2.7% | 3.0% | 2.8% | 2.7% | 2.6% | 2.5% | 2.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.